Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (2903) 2903
science & technology (2837) 2837
life sciences & biomedicine (2722) 2722
naphthalenes - therapeutic use (2591) 2591
male (2124) 2124
animals (1596) 1596
female (1419) 1419
naphthalenes - pharmacology (1256) 1256
biological and medical sciences (1146) 1146
medical sciences (1062) 1062
middle aged (923) 923
adult (877) 877
antifungal agents - therapeutic use (782) 782
pharmacology & pharmacy (772) 772
naphthalenes - administration & dosage (750) 750
rats (638) 638
pharmacology. drug treatments (636) 636
aged (605) 605
dermatology (565) 565
treatment outcome (565) 565
cinacalcet hydrochloride (511) 511
naphthalenes - adverse effects (494) 494
terbinafine (493) 493
mice (491) 491
dose-response relationship, drug (404) 404
morpholines - pharmacology (366) 366
administration, oral (340) 340
onychomycosis - drug therapy (329) 329
urology & nephrology (320) 320
neurosciences (309) 309
neurosciences & neurology (303) 303
antifungal agents - administration & dosage (291) 291
adolescent (290) 290
hyperparathyroidism, secondary - drug therapy (290) 290
analysis (271) 271
time factors (271) 271
antifungal agents (256) 256
benzoxazines - pharmacology (255) 255
rats, sprague-dawley (250) 250
abridged index medicus (249) 249
itraconazole - therapeutic use (236) 236
naphthalenes - chemistry (236) 236
disease models, animal (233) 233
double-blind method (232) 232
child (222) 222
drug therapy, combination (217) 217
naphthalenes - pharmacokinetics (214) 214
mycoses (212) 212
infectious diseases (203) 203
parathyroid hormone - blood (202) 202
chemistry (201) 201
cinacalcet (199) 199
care and treatment (197) 197
clinical trials as topic (197) 197
drug therapy (196) 196
naphthalene (195) 195
antibiotics. antiinfectious agents. antiparasitic agents (194) 194
administration, topical (188) 188
adapalene (184) 184
rats, wistar (181) 181
hyperparathyroidism, secondary - etiology (176) 176
calcium - blood (170) 170
piperidines - pharmacology (168) 168
pyrazoles - pharmacology (168) 168
physical sciences (165) 165
research (164) 164
fundamental and applied biological sciences. psychology (163) 163
kidney failure, chronic - complications (157) 157
biochemistry & molecular biology (152) 152
renal dialysis (151) 151
health aspects (150) 150
antifungal agents - adverse effects (149) 149
morpholines - therapeutic use (148) 148
onychomycosis (148) 148
toxicology (147) 147
follow-up studies (143) 143
pharmacology/toxicology (143) 143
cell line, tumor (142) 142
foot dermatoses - drug therapy (141) 141
cannabinoids - pharmacology (140) 140
benzoxazines (139) 139
acne vulgaris - drug therapy (138) 138
drug administration schedule (138) 138
prospective studies (138) 138
young adult (137) 137
antifungal agents - pharmacology (136) 136
cannabinoids (133) 133
hyperparathyroidism (132) 132
in vitro techniques (132) 132
naphthalenes (132) 132
drug interactions (131) 131
research article (130) 130
naphthalenes - metabolism (128) 128
dermatomycoses - drug therapy (127) 127
aged, 80 and over (126) 126
medicine & public health (126) 126
oncology (126) 126
parathyroid hormone (126) 126
general & internal medicine (122) 122
mycology (122) 122
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3962) 3962
German (89) 89
Japanese (80) 80
French (78) 78
Russian (63) 63
Italian (50) 50
Spanish (43) 43
Chinese (17) 17
Polish (16) 16
Portuguese (14) 14
Dutch (9) 9
Danish (6) 6
Swedish (3) 3
Finnish (2) 2
Romanian (2) 2
Turkish (2) 2
Bulgarian (1) 1
Croatian (1) 1
Czech (1) 1
Hebrew (1) 1
Slovak (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Chemotherapy-induced peripheral neuropathy: Prevention and treatment strategies
by Wolf, Sherry and Barton, Debra and Kottschade, Lisa and Grothey, Axel and Loprinzi, Charles
European journal of cancer (1990), ISSN 0959-8049, 2008, Volume 44, Issue 11, pp. 1507 - 1515
Hematology, Oncology and Palliative Medicine | Prevention | Chemotherapy | Neuropathy | Paclitaxel | Life Sciences & Biomedicine | Oncology | Science & Technology | Biological and medical sciences | Medical sciences | Pharmacology. Drug treatments | Tumors | Peripheral Nervous System Diseases - chemically induced | Magnesium - administration & dosage | Humans | Calcium - administration & dosage | Anticonvulsants - therapeutic use | Nootropic Agents - therapeutic use | Paclitaxel - therapeutic use | Randomized Controlled Trials as Topic | Antidepressive Agents, Tricyclic - therapeutic use | Peripheral Nervous System Diseases - prevention & control | Antineoplastic Agents - adverse effects | Vitamin E - therapeutic use | Glutamine - therapeutic use | Ketamine - therapeutic use | Acetylcarnitine - therapeutic use | Acetylcysteine - therapeutic use | Infusions, Intravenous | Naphthalenes - therapeutic use | Baclofen - therapeutic use | Pyridines - therapeutic use | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Therapeutic Strategies for the Treatment of Chronic Hyperuricemia: An Evidence-Based Update
by Cicero, Arrigo F. G and Fogacci, Federica and Kuwabara, Masanari and Borghi, Claudio
Medicina (Kaunas, Lithuania), ISSN 1010-660X, 01/2021, Volume 57, Issue 1, p. 58
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Urate Oxidase - therapeutic use | Humans | Propionates - therapeutic use | Evidence-Based Medicine | Polyethylene Glycols - therapeutic use | Thioglycolates - therapeutic use | Hyperuricemia - drug therapy | Gout Suppressants - therapeutic use | Allopurinol - therapeutic use | Benzbromarone - therapeutic use | Acetamides - therapeutic use | Febuxostat - therapeutic use | Phenylacetates - therapeutic use | Chronic Disease | Naphthalenes - therapeutic use | Probenecid - therapeutic use | Xanthine Oxidase - antagonists & inhibitors | Nitriles - therapeutic use | Pyridines - therapeutic use | Triazoles - therapeutic use | Uricosuric Agents - therapeutic use | Index Medicus | uric acid-lowering drugs | hyperuricemia | xanthine oxidase inhibitors | uric acid | uricosurics
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Targeting FGFR pathway in breast cancer
by Perez-Garcia, J and Muñoz-Couselo, E and Soberino, J and Racca, F and Cortes, J
Breast (Edinburgh), ISSN 0960-9776, 02/2018, Volume 37, pp. 126 - 133
Selective FGFR inhibitors | FGFR amplification | Multitargeted TKIs | Breast cancer | Fibroblast growth factor receptor (FGFR) | Tyrosine kinase receptor | Tyrosine kinase inhibitors | Oncology | Life Sciences & Biomedicine | Obstetrics & Gynecology | Science & Technology | Pyrazoles - therapeutic use | Humans | Receptors, Fibroblast Growth Factor - antagonists & inhibitors | Fibroblast Growth Factors - genetics | Phenylurea Compounds - therapeutic use | Drug Resistance, Neoplasm | Signal Transduction - genetics | Breast Neoplasms - drug therapy | Breast Neoplasms - metabolism | Drug Synergism | Fibroblast Growth Factors - metabolism | Breast Neoplasms - genetics | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Protein Kinase Inhibitors - therapeutic use | Pyrimidines - therapeutic use | Quinolones - therapeutic use | Receptors, Fibroblast Growth Factor - metabolism | Receptors, Fibroblast Growth Factor - genetics | Female | Quinolines - therapeutic use | Naphthalenes - therapeutic use | Benzimidazoles - therapeutic use | Quinoxalines - therapeutic use | Tyrosine | Fibroblast growth factors | Metastasis | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Sphingosine 1-Phosphate Receptor Modulators for the Treatment of Multiple Sclerosis
by Chaudhry, Burhan Z and Cohen, Jeffrey A and Conway, Devon S
Neurotherapeutics, ISSN 1933-7213, 10/2017, Volume 14, Issue 4, pp. 859 - 873
Neurology | Neurosciences | Biomedicine | Neurosurgery | Neurobiology | Pharmacology & Pharmacy | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Humans | Treatment Outcome | Clinical Trials as Topic | Thiazoles - therapeutic use | Indans - therapeutic use | Oxadiazoles - therapeutic use | Propanolamines - therapeutic use | Animals | Azetidines - therapeutic use | Benzyl Compounds - therapeutic use | Indoles - therapeutic use | Receptors, Lysosphingolipid - metabolism | Fingolimod Hydrochloride - therapeutic use | Naphthalenes - therapeutic use | Immunologic Factors - therapeutic use | Multiple Sclerosis - drug therapy | Multiple Sclerosis - metabolism | Multiple sclerosis | Lymphatic system | Developmental stages | Lymphocytes | Cardiomyocytes | Myocytes | Heart diseases | Lymph nodes | Regulatory approval | Sphingosine 1-phosphate | Index Medicus | Review
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Topical retinoids in acne vulgaris: Update on efficacy and safety
by Thielitz, Anja and Gollnick, Harald
American journal of clinical dermatology, ISSN 1175-0561, 2008, Volume 9, Issue 6, pp. 369 - 381
Tretinoin, therapeutic use | Retinaldehyde, therapeutic use | Isotretinoin, therapeutic use | Tazarotene, therapeutic use | Adapalene, therapeutic use | Retinoids, therapeutic use | Acne vulgaris, treatment | Retinol, therapeutic use | Life Sciences & Biomedicine | Dermatology | Science & Technology | Isotretinoin - therapeutic use | Adapalene | Humans | Acne Vulgaris - drug therapy | Retinoids - administration & dosage | Retinoids - therapeutic use | Tretinoin - therapeutic use | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Safety | Drug Therapy, Combination | Administration, Topical | Naphthalenes - therapeutic use | Nicotinic Acids - therapeutic use | Index Medicus
Journal Article
Details down arrow
6. Full Text Naftopidil for the treatment of lower urinary tract symptoms compatible with benign prostatic hyperplasia
by Hwang, Eu Chang and Gandhi, Shreyas and Jung, Jae Hung and Imamura, Mari and Kim, Myung Ha and Pang, Ran and Dahm, Philipp and Hwang, Eu Chang
Cochrane library, ISSN 1469-493X, 10/2018, Volume 2018, Issue 10, pp. CD007360 - CD007360
Piperazines | Plant Extracts | Benzilates | Adrenergic alpha‐Antagonists | Urology | Alpha‐blockers/Alpha‐1 adrenoceptors/Alpha antagonists/5‐alpha reductase inhibitors | Naphthalenes | Randomized Controlled Trials as Topic | Prostatic Hyperplasia | Urological Agents | Tamsulosin | Lower Urinary Tract Symptoms | Sulfonamides | Quality of Life | Prostatism | Benign prostatic hyperplasia | Treatment of Benign Prostatic Hyperplasia | Ethamsylate | Indoles | Pharmacologic/Medical Therapies | Medicine General & Introductory Medical Sciences | Drug Combinations | Naftopidil | Benign Prostatic Hyperplasia/Obstruction (Hypertrophy, Prostatic Hyperplasia) | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Benzilates - adverse effects | Naphthalenes - adverse effects | Benzilates - therapeutic use | Humans | Adrenergic alpha-Antagonists - therapeutic use | Male | Prostatic Hyperplasia - complications | Prostatism - drug therapy | Urological Agents - adverse effects | Adrenergic alpha-Antagonists - adverse effects | Ethamsylate - therapeutic use | Lower Urinary Tract Symptoms - drug therapy | Lower Urinary Tract Symptoms - etiology | Ethamsylate - adverse effects | Urological Agents - therapeutic use | Prostatism - etiology | Tamsulosin - adverse effects | Tamsulosin - therapeutic use | Piperazines - therapeutic use | Piperazines - adverse effects | Indoles - adverse effects | Sulfonamides - therapeutic use | Sulfonamides - adverse effects | Indoles - therapeutic use | Plant Extracts - therapeutic use | Naphthalenes - therapeutic use | Plant Extracts - adverse effects | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Effects of alprazolam and cannabinoid-related compounds in an animal model of panic attack
by Batista, Luara A and Haibara, Andrea S and Schenberg, Luiz C and Moreira, Fabricio A
Behavioural brain research, ISSN 0166-4328, 01/2017, Volume 317, pp. 508 - 514
Panic | Chemoreflex | Cannabinoid | CB1 receptor | Aversion | Benzodiazepines | receptor | Neurosciences | Neurosciences & Neurology | Life Sciences & Biomedicine | Behavioral Sciences | Science & Technology | Rats, Wistar | Male | Hypnotics and Sedatives - therapeutic use | Dose-Response Relationship, Drug | Heart Rate - drug effects | Benzamides - therapeutic use | Serotonin - therapeutic use | Enzyme Inhibitors - toxicity | Escape Reaction - drug effects | Potassium Cyanide - toxicity | Blood Pressure - drug effects | Morpholines - therapeutic use | Disease Models, Animal | Locomotion - drug effects | Analgesics - therapeutic use | Alprazolam - therapeutic use | Panic Disorder - drug therapy | Benzoxazines - therapeutic use | Panic Disorder - chemically induced | Cannabinoids - therapeutic use | Animals | Arachidonic Acids - therapeutic use | Serotonin - analogs & derivatives | Mice | Carbamates - therapeutic use | Naphthalenes - therapeutic use | Alprazolam | Analysis | Anxiety | Cyanides | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Onychomycosis
by Welsh, Oliverio, MD and Vera-Cabrera, Lucio, DrSc and Welsh, Esperanza, MD
Clinics in dermatology, ISSN 0738-081X, 2010, Volume 28, Issue 2, pp. 151 - 159
Dermatology | Life Sciences & Biomedicine | Science & Technology | Drug Administration Schedule | Onychomycosis - drug therapy | Administration, Oral | Foot Dermatoses - drug therapy | Humans | Ciclopirox | Administration, Cutaneous | Thiazoles - therapeutic use | Fluconazole - therapeutic use | Terbinafine | Antifungal Agents - therapeutic use | Foot Dermatoses - microbiology | Mitosporic Fungi - drug effects | Itraconazole - therapeutic use | Mitosporic Fungi - isolation & purification | Pyrimidines - therapeutic use | Voriconazole | Pyridones - therapeutic use | Drug Therapy, Combination | Onychomycosis - diagnosis | Morpholines - therapeutic use | Naphthalenes - therapeutic use | Triazoles - therapeutic use | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights